<?xml version="1.0" encoding="UTF-8"?>
<p id="Par33">In fact, various enzymes are important in the virus replication cycle. Enzymes are attractive targets that can be targeted by antiviral aptamers [
 <xref ref-type="bibr" rid="CR81">81</xref>]. RNA aptamers have been selected which could inhibit the enzyme activity of HIV tat and reverse transcriptase [
 <xref ref-type="bibr" rid="CR86">86</xref>], hepatitis C virus (HCV) NS3 protease/helicase [
 <xref ref-type="bibr" rid="CR87">87</xref>], NS5B RNA-dependent RNA polymerase [
 <xref ref-type="bibr" rid="CR88">88</xref>], SARS (severe acute respiratory syndrome) coronavirus (SCV) NTPase/ Helicase [nsP10] [
 <xref ref-type="bibr" rid="CR89">89</xref>]. Some aptamers developed as antiviral therapeutic agents are summarized in TableÂ 
 <xref rid="Tab2" ref-type="table">2</xref>. 
</p>
